Key result
In comatose out-of-hospital cardiac arrest survivors with acute myocardial infarction, levels of both hs-cTnI and hs-cTnT remained elevated for 72 hours, with no difference in kinetics between 24 and 48 hours of targeted temperature management.
Why the study?
Data were limited on high-sensitivity cardiac troponin kinetics in comatose OHCA patients, with and without AMI, undergoing targeted temperature management.
Does prolonged targeted temperature management (48 h) compared to standard duration (24 h) alter the kinetics of high-sensitivity troponins in comatose out-of-hospital cardiac arrest survivors?
RCT (n=114)
Single-blind
1:1
Yes
Does prolonged targeted temperature management (48 h) compared to standard duration (24 h) alter the kinetics of high-sensitivity troponins in comatose out-of-hospital cardiac arrest survivors?
Answers are grounded in this paper and cite their sources.
In comatose OHCA survivors with AMI, high-sensitivity troponin levels remain elevated for 72 hours during TTM regardless of cooling duration, suggesting these biomarkers may not be reliable for diagnosing new coronary events in this setting.
INTRODUCTION: Short term hypothermia has been suggested to have cardio protective properties in acute myocardial infarction (AMI) by reducing infarct size as assessed by troponins. There are limited data on the kinetics of these biomarkers in comatose out-of-hospital cardiac arrest (OHCA) patients, with and without AMI, undergoing targeted temperature management (TTM) in the ICU. PURPOSE: The aim of this post hoc analyses was to evaluate and compare the kinetics of two high-sensitivity cardiac troponins in OHCA survivors, with and without acute myocardial infarction (AMI), during TTM of different durations [24 h (standard) vs. 48 h (prolonged)]. METHODS: In a sub-cohort (n = 114) of the international, multicentre, randomized controlled study "TTH48" we measured high-sensitive troponin T (hs-cTnT), high-sensitive troponin I (hs-cTnI) and CK-MB at the following time points: Arrival, 24 h, 48 h and 72 h from reaching the target temperature range of 33 ± 1 °C. All patients diagnosed with an AMI at the immediate coronary angiogram (CAG)-18 in the 24-h group and 25 in the 48-h group-underwent PCI with stent implantation. There were no stent thromboses. RESULTS: Both the hs-cTnT and hs-cTnI changes over time were highly influenced by the cause of OHCA (AMI vs. non-AMI). In contrast to non-AMI patients, both troponins remained elevated at 72 h in AMI patients. There was no difference between the two time-differentiated TTM groups in the kinetics for the two troponins. CONCLUSION: In comatose OHCA survivors with an aetiology of AMI levels of both hs-cTnI and hs-cTnT remained elevated for 72 h, which is in contrast to the well-described kinetic profile of troponins in normotherm AMI patients. There was no difference in kinetic profile between the two high sensitive assays. Different duration of TTM did not influence the kinetics of the troponins. TRIAL REGISTRATION: Clinicaltrials.gov Identifier: NCT01689077, 20/09/2012.
No takes yet. Share an insight, caveat, or question.
Larsen et al. (2022) conducted an RCT in Out-of-hospital cardiac arrest (OHCA) with and without acute myocardial infarction (n=114). Targeted temperature management (TTM) for 48 hours vs. Targeted temperature management (TTM) for 24 hours was evaluated on Kinetics of high-sensitive troponin T (hs-cTnT) and high-sensitive troponin I (hs-cTnI) over 72 hours. In comatose out-of-hospital cardiac arrest survivors with acute myocardial infarction, levels of both hs-cTnI and hs-cTnT remained elevated for 72 hours, with no difference in kinetics between 24 and 48 hours of targeted temperature management.
Synapse has enriched 10 related papers. Consider them for comparative context: